Afeyan Noubar is of Moderna, Inc.. Currently has a direct ownership of 2.22 Million shares of MRNA, which is worth approximately $82 Million. The most recent transaction as insider was on Jul 31, 2024, when has been sold 15,000 shares (Common Stock) at a price of $120.32 per share, resulting in proceeds of $1,804,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.22M
0% 3M change
3.59% 12M change
Total Value Held $82 Million

AFEYAN NOUBAR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2024
SELL
Open market or private sale
$1,804,800 $120.32 p/Share
15,000 Reduced 0.67%
2,224,015 Common Stock
Jul 24 2024
SELL
Open market or private sale
$1,765,800 $117.72 p/Share
15,000 Reduced 0.67%
2,239,015 Common Stock
Jul 17 2024
SELL
Open market or private sale
$1,841,100 $122.74 p/Share
15,000 Reduced 0.66%
2,254,015 Common Stock
Jul 10 2024
SELL
Open market or private sale
$1,770,750 $118.05 p/Share
15,000 Reduced 0.66%
2,269,015 Common Stock
Jun 26 2024
SELL
Open market or private sale
$1,919,250 $127.95 p/Share
15,000 Reduced 0.65%
2,284,015 Common Stock
Jun 18 2024
SELL
Open market or private sale
$2,014,500 $134.3 p/Share
15,000 Reduced 0.65%
2,299,015 Common Stock
Jun 12 2024
SELL
Open market or private sale
$2,203,800 $146.92 p/Share
15,000 Reduced 0.64%
2,314,015 Common Stock
Jun 05 2024
SELL
Open market or private sale
$2,259,900 $150.66 p/Share
15,000 Reduced 0.76%
1,946,931 Common Stock
May 29 2024
SELL
Open market or private sale
$2,888,399 $144.42 p/Share
20,000 Reduced 1.01%
1,961,931 Common Stock
May 22 2024
SELL
Open market or private sale
$2,314,050 $154.27 p/Share
15,000 Reduced 0.75%
1,981,931 Common Stock
May 15 2024
SELL
Open market or private sale
$1,913,250 $127.55 p/Share
15,000 Reduced 0.75%
1,996,931 Common Stock
May 08 2024
SELL
Open market or private sale
$1,820,100 $121.34 p/Share
15,000 Reduced 0.74%
2,011,931 Common Stock
May 01 2024
SELL
Open market or private sale
$1,673,550 $111.57 p/Share
15,000 Reduced 0.73%
2,026,931 Common Stock
Apr 24 2024
SELL
Open market or private sale
$1,629,000 $108.6 p/Share
15,000 Reduced 0.73%
2,041,931 Common Stock
Apr 17 2024
SELL
Open market or private sale
$1,556,400 $103.76 p/Share
15,000 Reduced 0.72%
2,056,931 Common Stock
Apr 10 2024
SELL
Open market or private sale
$1,619,250 $107.95 p/Share
15,000 Reduced 0.72%
2,071,931 Common Stock
Apr 03 2024
SELL
Open market or private sale
$1,519,950 $101.33 p/Share
15,000 Reduced 0.71%
2,086,931 Common Stock
Mar 27 2024
SELL
Open market or private sale
$1,625,850 $108.39 p/Share
15,000 Reduced 0.71%
2,101,931 Common Stock
Mar 20 2024
SELL
Open market or private sale
$1,531,950 $102.13 p/Share
15,000 Reduced 0.7%
2,116,931 Common Stock
Mar 13 2024
SELL
Open market or private sale
$1,644,000 $109.6 p/Share
15,000 Reduced 0.7%
2,131,931 Common Stock
Nov 01 2023
SELL
Open market or private sale
$757,400 $75.74 p/Share
10,000 Reduced 0.46%
2,146,931 Common Stock
Oct 25 2023
SELL
Open market or private sale
$775,000 $77.5 p/Share
10,000 Reduced 0.46%
2,156,931 Common Stock
Oct 11 2023
SELL
Open market or private sale
$1,563,900 $104.26 p/Share
15,000 Reduced 0.69%
2,166,931 Common Stock
Oct 04 2023
SELL
Open market or private sale
$1,530,750 $102.05 p/Share
15,000 Reduced 0.68%
2,181,931 Common Stock
Sep 27 2023
SELL
Open market or private sale
$993,700 $99.37 p/Share
10,000 Reduced 0.45%
2,196,931 Common Stock

Also insider at

MCRB
Seres Therapeutics, Inc. Healthcare
RUBY
Rubius Therapeutics, Inc. Healthcare
EVLO
Evelo Biosciences, Inc. Healthcare
OMGA
Omega Therapeutics, Inc. Healthcare
AFEYAN NOUBAR

Afeyan Noubar

Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA